Dr Lucy Bartho
Postdoctoral Research Fellow
Department of Obstetrics, Gynaecology and Newborn Health
32 Scholarly works
9 Projects
HIGHLIGHTS
2026
Journal article
Thrombospondin-1 (THBS1) is dysregulated in preeclampsia
DOI: 10.1016/j.placenta.2025.11.0132025
Journal article
Plasma proteomics can identify associations between pregnancy complications and future health risks.
DOI: 10.1016/j.placenta.2025.08.1492025
Journal article
Ingenol Mebutate as a Novel Therapeutic Candidate for preeclampsia.
DOI: 10.1016/j.placenta.2025.08.2942025
Journal article
The association between circulating SIGLEC6 and preeclampsia: observational studies of seven cohorts
DOI: 10.1016/j.ebiom.2025.1058702025
Research grants (other domestic)
A Novel Blood Test for Stillbirth
2025
Research grants (ARC, NHMRC, MRFF)
Novel Methods to Identify Women at Risk of Preeclampsia Late in Pregnancy.
2024
Research grants (other domestic)
Aptamer Biomarker Validation for Prevention of Stillbirth
RECENT SCHOLARLY WORKS
2025
Journal article
Reduced circulating NrCAM as a biomarker for fetal growth restriction
DOI: 10.1016/j.ebiom.2025.1058542025
Journal article
Alpha-fetoprotein (AFP) is reduced at 36 weeks’ gestation in pregnancies destined to deliver small for gestational age infants
DOI: 10.1016/j.ejogrb.2025.03.0272025
Journal article
Cystatin 6 (CST6) and Legumain (LGMN) are potential mediators in the pathogenesis of preeclampsia
DOI: 10.1038/s41598-025-96823-92024
Journal article
Trophoblast Side-Population Markers are Dysregulated in Preeclampsia and Fetal Growth Restriction
DOI: 10.1007/s12015-024-10764-w2024
Journal article
Elucidating the function of Sialic acid-binding immunoglobulin-like lectin-6 (SIGLEC6) in preeclampsia
DOI: 10.1016/j.placenta.2024.07.2442024
Journal article
Neuronal cell adhesion molecule (NrCAM) is reduced in pregnancies with small for gestational age.
DOI: 10.1016/j.placenta.2024.07.197
RECENT PROJECTS
2024
Research contracts (non-grants)
(MSA) Statistical Support for Perinatal Research
2025
Research grants (ARC, NHMRC, MRFF)
TIM TAMS: Placental Health Test to Prevent Stillbirths and Adverse Pregnancy Outcomes